• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:张琳,段修冉,刘伟.中药致肝毒性及相关肝损伤辨析与风险归因研究进展[J].药学研究,2026,45(9):1058-1064[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 228次   下载 216次 本文二维码信息
码上扫一扫!
中药致肝毒性及相关肝损伤辨析与风险归因研究进展
张琳1,段修冉1,刘伟2
字体:加大+|默认|缩小-
(1.山东第一医科大学第二附属医院药学部,山东 泰安 271000;2.齐鲁工业大学<山东省科学院>,山东省分析测试中心,山东 济南 250014)
摘要:
中药是我国传统医药体系的核心组成部分,是临床防病治病的重要物质基础。随着中医药临床应用的广泛推广,中药用药安全已成为行业与公众关注的核心议题,其中中药相关药物性肝损伤(DILI)的发生机制与风险防控是研究热点。目前学界存在固有肝毒性与不合理用药致肝损伤概念混淆、肝毒性药材统计口径不统一等问题,易引发公众对中药安全性的误解。因此,本文基于中药系统毒理学数据库权威数据、《中国药典》2025年版毒性药材分级标准,结合近年核心文献报道,明确界定中药固有肝毒性与用药相关肝损伤的核心差异,系统梳理固有肝毒性中药的分类、核心毒性成分与肝损伤作用机制,建立非固有毒性药材肝损伤的归因甄别标准,甄别其核心风险因素。
关键词:  固有肝毒性中药  药物性肝损伤  毒性成分  风险因素  合理用药  风险规避
DOI:10.13506/j.cnki.jpr.2026.09.015
基金项目:
收稿日期:2026-05-09   修回日期:2026-07-28   出版日期:2026-09-30
Research progress on the differentiation and risk attribution of traditional Chinese medicine induced hepatotoxicity and related liver injury
ZHANG Lin1,DUAN Xiuran1,LIU Wei2
(1.Department of Pharmacy,The Second Affiliated Hospital of Shandong First Medical University,Taian 271000,China;2.Qilu University of Pharmaceutical Technology,Shandong Analytical and testing Center,Jinan 250014,China)
Abstract:
Traditional Chinese medicine (TCM) is a core component of China's traditional medical system and serves as a crucial material foundation for disease prevention and treatment in clinical practice. With the widespread application of TCM in clinical settings, drug safety has become a central concern for both the industry and the public, particularly regarding the mechanisms and risk prevention of drug-induced liver injury (DILI) associated with TCM. Currently, academic circles face challenges such as confusion between intrinsic hepatic toxicity and liver damage caused by inappropriate medication use, as well as inconsistent criteria for classifying hepatotoxic herbs—issues that can lead to public misunderstanding about TCM safety. Therefore, based on authoritative data from the System Toxicology Database of Traditional Chinese Medicine and the 2025 edition of the Chinese Pharmacopoeia's classification standards for toxic herbs, and incorporating recent key literature, this article clearly defines the fundamental differences between intrinsic hepatic toxicity and drug-related liver injury in TCM. It systematically organizes the classification of intrinsically hepatotoxic herbs, their key toxic components, and underlying mechanisms of liver injury, establishes diagnostic criteria for attributing liver injury caused by non-intrinsically toxic herbs, and identifies their core risk factors.
Key words:  Inherent hepatotoxic traditional Chinese medicine  Drug-induced liver injury  Toxic components  Risk factors  Rational medication  Risk avoidance
今日访问量:2486    总访问量:55338925
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司